Aa Aa Aa
  • Investor Information Overview

Webcast ImageWebcast
Q2 2014 Sucampo Pharmaceuticals, Inc. Earnings Conference Call (Live)
08/05/14 at 8:30 a.m. ET
Corporate Profile
Sucampo Pharmaceuticals, Inc. is a publicly traded (NASDAQ: SCMP) global biopharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and are also considering o  More >>
Stock Quote
SCMP (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Change (%) Stock is Down 0.02 (0.32%)
Data as of 07/24/14 4:00 p.m. ET
Refresh quote
Recent NewsRSS   | More >>
07/23/14Sucampo Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone)Printer Friendly Version
07/22/14Sucampo Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results and Corporate Update Teleconference and Webcast on August 5Printer Friendly Version
07/07/14Swissmedic Approves AMITIZA(R) (Lubiprostone) for the Treatment of Opioid-Induced ConstipationPrinter Friendly Version
06/17/14AMITIZA(R) (Lubiprostone) Receives NICE RecommendationPrinter Friendly Version
Upcoming Events
08/05/14 8:30 a.m. ET
Q2 2014 Sucampo Pharmaceuticals, Inc. Earnings Conference Call
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.